Cost-effectiveness and estimated health benefits of treating patients with vitamin D in pre-dialysis
Year of publication: |
2020
|
---|---|
Authors: | Snyder, Sophie ; Hollenbeak, Christopher S. ; Kalantar-Zadeh, Kamyar ; Gitlin, Matthew ; Ashfaq, Akhtar |
Published in: |
Forum for health economics & policy : an evolving collection of symposia on important health care issues. - Berlin : De Gruyter, ISSN 1558-9544, ZDB-ID 2233218-2. - Vol. 23.2020, 1, p. 1-15
|
Subject: | 25-hydroxyvitamin D | cardiovascular disease | chronic kidney disease (CKD) | cost-effectiveness | disease progression | economic analysis | end-stage renal disease (ESRD) | fracture | health care costs | parathyroid hormone (PTH) | pre-dialysis care | secondary hyperparathyroidism (SHPT) | Gesundheitskosten | Health care costs | Krankheit | Disease | Kosten-Nutzen-Analyse | Cost-benefit analysis | Herzkrankheit | Heart disease | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Infektionskrankheit | Infectious disease | Chronische Krankheit | Chronic disease |
-
The costs of COVID-19 and the cost-effectiveness of testing
González López-Valcárcel, Beatriz, (2021)
-
Using electronic medical records in admission decisions : a cost effectiveness analysis
Ben-Assuli, Ofir, (2013)
-
Torrini, Irene, (2022)
- More ...
-
Long-term employment effects of surviving cancer
Moran, John R., (2011)
-
The Effect of Generic Competition on Prescription to Over-the-Counter Switching
Hollenbeak, Christopher S., (1999)
-
Fleurence, Rachael L., (2007)
- More ...